American Healthcare REIT, Inc. (NYSE:AHR) Shares Purchased by Csenge Advisory Group

Csenge Advisory Group boosted its stake in shares of American Healthcare REIT, Inc. (NYSE:AHRFree Report) by 6.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 25,322 shares of the company’s stock after purchasing an additional 1,554 shares during the period. Csenge Advisory Group’s holdings in American Healthcare REIT were worth $720,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Wilmington Savings Fund Society FSB purchased a new position in shares of American Healthcare REIT during the third quarter worth $28,000. GAMMA Investing LLC boosted its stake in shares of American Healthcare REIT by 104.1% during the 4th quarter. GAMMA Investing LLC now owns 988 shares of the company’s stock worth $28,000 after acquiring an additional 504 shares in the last quarter. Carolina Wealth Advisors LLC acquired a new position in American Healthcare REIT in the 4th quarter worth about $29,000. Quarry LP purchased a new stake in shares of American Healthcare REIT in the third quarter valued at approximately $33,000. Finally, Decker Retirement Planning Inc. acquired a new stake in American Healthcare REIT in the 4th quarter valued at $37,000. 16.68% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on AHR. Morgan Stanley upped their price target on shares of American Healthcare REIT from $27.00 to $29.00 and gave the stock an “overweight” rating in a research report on Monday, December 30th. Royal Bank of Canada increased their price target on American Healthcare REIT from $28.00 to $30.00 and gave the company an “outperform” rating in a report on Monday, November 18th. Finally, Truist Financial upped their price objective on shares of American Healthcare REIT from $27.00 to $29.00 and gave the company a “buy” rating in a report on Friday, November 15th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $26.00.

Check Out Our Latest Analysis on American Healthcare REIT

American Healthcare REIT Stock Performance

NYSE:AHR opened at $28.18 on Tuesday. The firm has a market capitalization of $4.31 billion and a PE ratio of -58.70. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.37 and a quick ratio of 0.37. American Healthcare REIT, Inc. has a 12 month low of $12.81 and a 12 month high of $29.99. The business’s fifty day moving average price is $28.26 and its 200 day moving average price is $25.64.

American Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, January 17th. Stockholders of record on Tuesday, December 31st were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.55%. The ex-dividend date was Tuesday, December 31st. American Healthcare REIT’s payout ratio is currently -208.33%.

American Healthcare REIT Company Profile

(Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

See Also

Institutional Ownership by Quarter for American Healthcare REIT (NYSE:AHR)

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.